M.FactorV
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
Margulies KB
When women feel less inflamed and recover more efficiently from workouts, consistency improves
If nausea is a concern, eating a small, protein-rich breakfast before or shortly after injection can buffer stomach irritation
(2026) Alcohol is not formally contraindicated with GLP-1 medications, but it amplifies nausea, hypoglycemia risk, and dehydration